Loading clinical trials...
Loading clinical trials...
A Phase 2 Study of Docetaxel and Carboplatin for Treatment of Patients With Metastatic, Castration Resistant Prostate Cancer and Germline or Somatic DNA Repair Deficiency
Conditions
Interventions
Carboplatin
Docetaxel
Locations
3
United States
VA Greater Los Angeles - West LA
Los Angeles, California, United States
VA Ann Arbor Health Care System
Ann Arbor, Michigan, United States
VA Puget Sound Health Care System
Seattle, Washington, United States
Start Date
November 1, 2016
Primary Completion Date
April 1, 2021
Completion Date
April 1, 2021
Last Updated
August 5, 2021
NCT04693377
NCT06389786
NCT05398302
NCT06244004
NCT04550494
NCT04857502
Lead Sponsor
Seattle Institute for Biomedical and Clinical Research
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions